Las Vegas, NV -- (SBWIRE) -- 01/22/2014 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: Pacific Biosciences of California(NASDAQ:PACB), Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD), Sarepta Therapeutics Inc (NASDAQ:SRPT), Denison Mines Corp (USA)(NYSEMKT:DNN)
Pacific Biosciences of California (NASDAQ:PACB) was a volume gainer of 4.14 million shares and the average volume of the stock remained 774,635.00 shares. The stock opened the session at $6.57 and finished at the end of the day at $7.77 and the stock escalated 19.54%.The market capitalization of the stock remained 514.00 million. Pacific Biosciences of California, Inc. develops, manufactures, and markets an integrated platform for genetic analysis. The company was formerly known as Nanofluidics, Inc. Pacific Biosciences of California, Inc. was founded in 2000 and is headquartered in Menlo Park, California.
For How Long PACB will fight for Profitability? Read This Trend Analysis report
In the preceding trading session, Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) exchanged 4.11 million shares and the average volume remained 991,952.00 shares. The stock closed the session at $14.75 with the gain of 16.51%. Ironwood Pharmaceuticals, Inc., an entrepreneurial pharmaceutical company, discovers, develops, and commercializes human therapeutic products. The company was formerly known as Microbia, Inc. and changed its name to Ironwood Pharmaceuticals, Inc. in April 2008.
Will IRWD Continue To Move Higher? Find Out Here
Sarepta Therapeutics Inc (NASDAQ:SRPT) enhanced 4.63% and its closing price was $28.02. The volume of the stock was 4.11 million shares and the average volume remained 2.25 million shares. The market capitalization of the stock remained 1.05 billion. The beta of the stock remained 0.92. Sarepta Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery and development of RNA-based therapeutics for the treatment of rare and infectious diseases. Sarepta Therapeutics, Inc. was founded in 1980 and is headquartered in Cambridge, Massachusetts.
Why Should Investors Buy SRPT After The Recent Gain? Just Go Here and Find Out
Denison Mines Corp (USA)(NYSEMKT:DNN) exchanged 3.85 million shares in the previous trading session, and its average trading remained 1.01 million shares. DNN advanced 5.30% and it closed the trading at $1.39. The market capitalization of the stock remained 626.01 million. Denison Mines Corp. engages in the exploration, development, mining, and milling of uranium in Canada, Zambia, and Mongolia. The company was formerly known as International Uranium Corporation and changed its name to Denison Mines Corp. in December 2006
For How Long DNN’s Gloss will Attract Investors? Find out via this report
About Equity Observer:
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/">http://www.equityobserver.com/&l...; employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/>
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)